On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Glenn Heller

ResearcherPublications, citations & collaboration network

Glenn Heller is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Glenn Heller have?

ScholarIQindexed works

Glenn Heller has 553 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Glenn Heller have?

ScholarIQcitation count

Glenn Heller has 32,636 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Glenn Heller?

ScholarIQh-index

Glenn Heller has an h-index of 102 in OpenAlex.

What is the i10-index of Glenn Heller?

ScholarIQi10-index

Glenn Heller has an i10-index of 245 in OpenAlex.

What is the ORCID of Glenn Heller?

ScholarIQorcid

The ORCID for Glenn Heller is on the source record.

What is the OpenAlex record for Glenn Heller?

ScholarIQopenalex

The OpenAlex for Glenn Heller is on the source record.

What are the most-cited papers on Glenn Heller?

ScholarIQmost cited works
Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes
Ethan Basch, Xiaoyu Jia, Glenn Heller, Allison Barz, Laura Sit, M. Fruscione, Mark Appawu, Alexia Iasonos, Thomas M. Atkinson, Shari Goldfarb, Ann Culkin, Mark G. Kris, Deborah Schrag
JNCI Journal of the National Cancer Institute. 2009631 Citations
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
Howard I. Scher, Xiaoyu Jia, Johann S. de Bono, Martin Fleisher, Kenneth J. Pienta, Derek Raghavan, Glenn Heller
The Lancet Oncology. 2009615 CitationsOPEN ACCESS
Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer
Howard I. Scher, Glenn Heller, Arturo Molina, Gerhardt Attard, Daniel C. Danila, Xiaoyu Jia, Weimin Peng, Shahneen Sandhu, David Olmos, Ruth Riisnaes, Robert G. McCormack, Tomasz Burzykowski, Thian Kheoh, Martin Fleisher, Marc Buyse, Johann S. de Bono
Journal of Clinical Oncology. 2015382 CitationsOPEN ACCESS
Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer
Howard I. Scher, Xiaoyu Jia, Kim Chi, Ronald de Wit, William R. Berry, Peter Albers, Brian S. Henick, David Waterhouse, Dean Ruether, Peter J. Rosen, Anthony A. Meluch, Luke T. Nordquist, Peter Venner, Axel Heidenreich, Luis Chu, Glenn Heller
Journal of Clinical Oncology. 2011250 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account